← Back to Dashboard

Descovy

Dual NRTI

Constituent drugs (2)

Emtricitabine

Could not render structureView on PubChem
3D not available

Tenofovir Alafenamide

Could not render structureView on PubChem
3D not available

Chemical Identifiers

Clinical Development by Virus1

Human immunodeficiency virus 1
HIV-1
Target: Viral RT
Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
Japan
Approval ref (pmda.go.jp) PMDA approved Dec. 9, 2016fixed-dose combination of Emtricitabine, Tenofovir alafenamide.